Kim, M.Y. and Goldberg, J.D. The effects of outcome misclassification and measurement error on the design and analysis of therapeutic equivalence trials. Statistics in Medicine 2001; 2065-2078.
Kim, M.Y. and Xue, X. The analysis of multivariate interval-censored survival data. Statistics in Medicine 2002; 21: 3715 – 3726.
Kim, M.Y. and Xue, X. Likelihood ratio and a Bayesian approach were superior to standard noninferiority analysis when the noninferiority margin varied with the control event rate. Journal of Clinical Epidemiology 2004; 57: 1253-1261.
Petri, M., Kim, M., Kalunian, K., et al. Combined oral contraceptives are not associated with an increased rate of flare in SLE patients in the SELENA Trial. New England Journal of Medicine 2005; 353:2550 - 2558.
Ginzler, E., Dooley, M., Aranow, C., Kim, M., et al. Comparison of mycophenolate mofetil to intravenous cyclophosphamide for induction therapy of severe active lupus nephritis. New England Journal of Medicine 2005; 353: 2219 - 2228.
Buyon, J., Petri, M., Kim, M., et al. . Estrogen/Cyclic progesterone replacement is associated with an increased rate of mild/moderate but not severe flares in SLE: The SELENA Trial. Annals of Internal Medicine 2005; 953 - 962.
Sheng, D. and Kim, M.Y. The effects of non-compliance on intent-to-treat analysis of equivalence trials. Statistics in Medicine 2006; 25:1183-1199.
Kim, M.Y., Xue, X., Du, E. Approaches for calculating power for case-cohort studies. Biometrics 2006; 62: 929-922.
Xue, X., Kim, M., and Shore, R. Cox regression analysis in presence of collinearity: an application to assessment of health risks associated with occupational radiation exposure. Lifetime Data Analysis 2007; 13:333-350.
Kim, M.Y. Using the instrumental variables estimator to analyze non-inferiority trials with non-compliance. Journal of Biopharmaceutical Statistics 2010; 20:745-758.
Heo, M., Kim, Y., Xue, X., Kim, M. Sample size requirement to detect an intervention effect at the end of follow-up in a longitudinal cluster randomized trial. Statistics in Medicine 2010; 29:382-290.
Xie, X., Xue, X., Gange, S., Strickler, H., Kim, M., and the WIHS HPV Study Group. Estimationand inference on correlations between biomarkers with repeated measures and left-censoring dueto minimum detection levels. Statistics in Medicine 2012; 31:2275-2289
Wang, C., Hall, C., Kim, M. A comparison of power analysis methods for evaluating the effects of a predictor on slopes in longitudinal designs with missing data. Statistical Methods in Medical Research 2015; 24:1009-1029
Buyon, J., Kim, M., Guerra, M., Laskin, C., Petri, M., Lockshin, M., Sammaritano, L., Branch, W., Porter, F., Sawitzke, A., Merrill, J., Stephenson, M., Cohn, E., Garabet, L., Salmon, J. Predictors of pregnancy outcome in a prospective multiethnic cohort of lupus patients. Annals of Internal Medicine 2015; 163:153-163
Kim, M., Wang, C., Xue, X. Assessing the influence of treatment non-adherence on non-inferiority trials using the tipping point approach. Statistics in Medicine 2019; 38:650-659
Fazzari, M., and Kim, M. Subgroup discovery in non-inferiority trials. Statistics in Medicine 2021; 40: 5174-5187.
Lee, S., Bagiella, E., Vaughan,R., Govindarajulu, U., Christos, P., Esserman, D., Zhong, H., Kim, M. COVID-19 Pandemic as a Change Agent in the Structure and Practice of Statistical Consulting Centers. The American Statistician 2022; 76;152-158.
Choi, J., Xue, X., Kim, M. Non-inferiority trials with time-to-event data: Clarifying the impact of censoring. Journal of Biopharmaceutical Statistics 2023; Apr 12:1-18.